Pharmaceutical Facility Design Sourcing Center

Clinical Trial Services & Solutions Sourcing Center

According to the Alliance of Regenerative Medicine, there were 1,220 clinical trials ongoing at the end of 2020, with 152 of those trials in Phase 3, supporting the FDA's and EMA's predictions they will approve 10-20 cell and gene therapies each year by 2025.

The development of cell and gene therapy trials is both complex and challenging as well as subject to heavy regulatory scrutiny. As new and emerging biotechs and even established pharma drive their research forward through clinical trials, anticipating challenges can be key to bringing therapies from bench to bedside. Biotechs will be faced with important decisions when it comes to clinical development and selecting the right CRO partner is one of those decisions.

How can we help?

Looking for help with your Cell & Gene Therapy clinical trial? If you're searching for information or a supplier, let Life Science Connect lend you a hand.

Submit A Question

Cell & Gene Therapy Clinical Trial Services Provider - Applied Biosystems by Thermo Fisher Scientific, qPCR
Applied Biosystems by Thermo Fisher Scientific, qPCR

For reproducible results, choose reliable qPCR reagents. Optimized real-time PCR (qPCR) analysis enables sensitive and specific quantification of nucleic acids. Reagent selection plays a critical role in any qPCR or RT-qPCR protocol to help ensure optimal performance and reliable results. Set your analysis up for success by choosing an Applied Biosystems real-time PCR master mix or reagent.

Cell & Gene Therapy Clinical Trial Services Provider - Avance Clinical
Avance Clinical

Avance Clinical is a full-service CRO with over three decades of experience, offering high-quality clinical research services across Australia, New Zealand, Asia, North America, and Europe. We specialize in guiding biotechs from pre-clinical development to late-phase studies, with our ClinicReady team for early phases and GlobalReady team for Phase II to III, ensuring expert support at every stage.

Capabilities

Cell & Gene Therapy Clinical Trial Services Provider - inSeption Group
inSeption Group

inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.


Have questions about your Cell & Gene therapy clinical trial?

The Life Science Connect team can help. We'll match your needs with the right companies.

Contact us via email for assistance.


Cell & Gene Therapy Clinical Trial Services Provider - MRN – Medical Research Network
MRN – Medical Research Network

At MRN we understand the complexities of today's clinical trial environment and the burden this places on patients, clients and sites.

Our services are designed to ease these burdens, from community researchers through to investigator site professional support, accelerating patient recruitment and retention.

We work to maximize the efficiency of clinical trials for drug developers, by improving the patient's experience, no matter where their community is in the world.

Cell & Gene Therapy Clinical Trial Services Provider - Novotech
Novotech

Founded in 1997, Novotech is a global full-service clinical CRO focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. Novotech offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with 5,000+ clinical projects. The company has 34 office locations and a team of 3,000+ professionals worldwide.

Cell & Gene Therapy Clinical Trial Services Provider - OpenClinica
OpenClinica

OpenClinica is transforming healthcare through innovative cloud technology that simplifies running clinical trials. Proven in over 10,000 studies worldwide, the OpenClinica platform is trusted by leading biopharmaceutical companies, contract research organizations, academic institutions, and government agencies. OpenClinica is used across a wide spectrum of clinical research, including drug, device, and diagnostic trials, global health studies involving 200,000+ patients, adaptive platform trials, and clinical trials for some of the first gene therapies to be approved for market.

Capabilities


Cell & Gene Therapy Clinical Trial Services Provider - Parexel
Parexel

Parexel is among the world's largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help lifesaving treatments reach patients faster. At Parexel, we design solutions With Heart™️. That means we bring an unparalleled passion, unrelenting commitment to problem-solving, and an empathetic focus on the patient experience to expertly propel clinical trials forward.

Capabilities

Cell & Gene Therapy Clinical Trial Services Provider - ProPharma
ProPharma

As the world's largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate their partners' most high-profile drug and device programs.

Capabilities

Cell & Gene Therapy Clinical Trial Services Provider - Synthego Corporation
Synthego Corporation

Synthego is a genome engineering company that enables life science research and therapy development with a mission of increased access to engineered therapies for all patients. With unparalleled CRISPR expertise, state-of-the-art GMP capabilities, and a continuum of product offerings, Synthego supports CRISPR-edited cell and gene therapeutic development at every step, from R&D through IND submission to first-in-human trials.

Capabilities


Cell & Gene Therapy Clinical Trial Services Provider - Veristat
Veristat

Veristat, a global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 26 years' experience in clinical trial planning and execution, Veristat is equipped to support any development program. Our team has prepared over 100 marketing applications for approval with global regulatory authorities in the last 10 years alone.

Capabilities